Hiv Drug
-
{
- All
- News
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
New Long Acting Oral HIV Regimen Meets Primary Endpoints In Phase 3 Trials
The combination of islatravir and lenacapavir targets multiple stages of HIV-1 replication, potentially offering people with HIV who are virologically suppressed a novel, long-acting oral single-tablet regimen.
-
Delhi Man Critical After AI Advice: Risks Of HIV Drug Misuse Explained
A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when properly prescribed, but dangerous when AI gives it.
-
Delhi Man Critical After AI Advice: Risks Of HIV Drug Misuse Explained
A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when properly prescribed, but dangerous when AI gives it.
-
HIV-Prevention Drug To Be Available For Rs 3,500 A Year From 2027
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 or Rs 3,548 a year in more than 100 countries from 2027, Unitaid and the Gates Foundation said Wednesday.
-
Why We Still Need A Cure For HIV Despite Powerful Treatments
Over the past three decades there have been amazing advances in treating and preventing HIV.
-
Lenacapavir: The 'Breakthrough Of The Year' Drug For HIV Care
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication.
-
WHO Testing Interim Data From COVID-19 Trial On HIV Drugs
The World Health Organization is looking at interim data from its large multi-country trial of the combination of HIV drugs Lopinavir and Ritonavir to treat COVID-19 patients, the UN agency's chief scientist Soumya Swaminathan said on Thursday.
-
In Russia, A Black Market For HIV Drug For COVID-19 Treatment
A black market has developed in Russia for an antiviral HIV drug explored as a possible treatment for COVID-19, the respiratory disease caused by the new coronavirus, according to sellers, HIV activists and the head of the drug's main Russian producer.
-
Surprising Monkey Study Could Lead To 'Functional' HIV Cure
But when a drug already taken by thousands of people for intestinal conditions appeared to control the monkey version of HIV, it got the attention of the director of the National Institutes of Allergy and Infectious Diseases.
-
Surprising Monkey Study Could Lead To 'Functional' HIV Cure
But when a drug already taken by thousands of people for intestinal conditions appeared to control the monkey version of HIV, it got the attention of the director of the National Institutes of Allergy and Infectious Diseases.
-
UK Court Says State Health System Can Fund Preventative HIV Drug
A high court judge ruled on Tuesday that an HIV pill to prevent infection can be funded by the state health service in England, in a victory for AIDS campaigners who have been calling for its widespread use.
-
Enzyme May Cut Heart Disease Risk Caused By HIV Drug
Researchers have identified an enzyme that is likely to lower the risk of heart related diseases caused by antiviral medicines used for human immunodeficiency virus (HIV).
-
Enzyme May Cut Heart Disease Risk Caused By HIV Drug
Researchers have identified an enzyme that is likely to lower the risk of heart related diseases caused by antiviral medicines used for human immunodeficiency virus (HIV).
-
HIV Drug May Affect Foetal Development: Study
An anti-retroviral drug used to prevent the transmission of HIV from mother to child may have small but significant effects on infant development, a new study has claimed.
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
New Long Acting Oral HIV Regimen Meets Primary Endpoints In Phase 3 Trials
The combination of islatravir and lenacapavir targets multiple stages of HIV-1 replication, potentially offering people with HIV who are virologically suppressed a novel, long-acting oral single-tablet regimen.
-
Delhi Man Critical After AI Advice: Risks Of HIV Drug Misuse Explained
A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when properly prescribed, but dangerous when AI gives it.
-
Delhi Man Critical After AI Advice: Risks Of HIV Drug Misuse Explained
A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when properly prescribed, but dangerous when AI gives it.
-
HIV-Prevention Drug To Be Available For Rs 3,500 A Year From 2027
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 or Rs 3,548 a year in more than 100 countries from 2027, Unitaid and the Gates Foundation said Wednesday.
-
Why We Still Need A Cure For HIV Despite Powerful Treatments
Over the past three decades there have been amazing advances in treating and preventing HIV.
-
Lenacapavir: The 'Breakthrough Of The Year' Drug For HIV Care
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication.
-
WHO Testing Interim Data From COVID-19 Trial On HIV Drugs
The World Health Organization is looking at interim data from its large multi-country trial of the combination of HIV drugs Lopinavir and Ritonavir to treat COVID-19 patients, the UN agency's chief scientist Soumya Swaminathan said on Thursday.
-
In Russia, A Black Market For HIV Drug For COVID-19 Treatment
A black market has developed in Russia for an antiviral HIV drug explored as a possible treatment for COVID-19, the respiratory disease caused by the new coronavirus, according to sellers, HIV activists and the head of the drug's main Russian producer.
-
Surprising Monkey Study Could Lead To 'Functional' HIV Cure
But when a drug already taken by thousands of people for intestinal conditions appeared to control the monkey version of HIV, it got the attention of the director of the National Institutes of Allergy and Infectious Diseases.
-
Surprising Monkey Study Could Lead To 'Functional' HIV Cure
But when a drug already taken by thousands of people for intestinal conditions appeared to control the monkey version of HIV, it got the attention of the director of the National Institutes of Allergy and Infectious Diseases.
-
UK Court Says State Health System Can Fund Preventative HIV Drug
A high court judge ruled on Tuesday that an HIV pill to prevent infection can be funded by the state health service in England, in a victory for AIDS campaigners who have been calling for its widespread use.
-
Enzyme May Cut Heart Disease Risk Caused By HIV Drug
Researchers have identified an enzyme that is likely to lower the risk of heart related diseases caused by antiviral medicines used for human immunodeficiency virus (HIV).
-
Enzyme May Cut Heart Disease Risk Caused By HIV Drug
Researchers have identified an enzyme that is likely to lower the risk of heart related diseases caused by antiviral medicines used for human immunodeficiency virus (HIV).
-
HIV Drug May Affect Foetal Development: Study
An anti-retroviral drug used to prevent the transmission of HIV from mother to child may have small but significant effects on infant development, a new study has claimed.
